Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic Non Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02140736
What this trial is testing

Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology

Who this might be right for
Chemotherapy-induced Symptomatic AnemiaSolid TumorsMalignant Hemopathies+2 more
Hospira, now a wholly owned subsidiary of Pfizer 2,333
Not applicableStudy completedNCT00049465
What this trial is testing

Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00089011
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more
Fred Hutchinson Cancer Center 150
Early research (Phase 1)Study completedNCT00004101
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 35
Large-scale testing (Phase 3)Study completedNCT00115167
What this trial is testing

Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study

Who this might be right for
AnemiaCancer
Amgen 371
Testing effectiveness (Phase 2)Study completedNCT00782067
What this trial is testing

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Who this might be right for
Leukemia
Novartis Pharmaceuticals 116
Not applicableActive Not RecruitingNCT06002828
What this trial is testing

Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

Who this might be right for
Acute Lymphoblastic LeukemiaHodgkin LymphomaNon-Hodgkin Lymphoma
ECOG-ACRIN Cancer Research Group 2,000
Early research (Phase 1)Study completedNCT05665530
What this trial is testing

PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies

Who this might be right for
Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Mantle Cell Lymphoma (MCL)+9 more
Prelude Therapeutics Incorporated 86
Testing effectiveness (Phase 2)UnknownNCT02507479
What this trial is testing

Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

Who this might be right for
Non Hodgkin LymphomaHodgkin LymphomaChronic Lymphocytic Leukemia+1 more
Sheba Medical Center 24
Testing effectiveness (Phase 2)Study completedNCT00120679
What this trial is testing

Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy

Who this might be right for
Non-Small Cell Lung CancerAnemia
Amgen
Post-approval studies (Phase 4)Study completedNCT00352703
What this trial is testing

PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation

Who this might be right for
Non-Hodgkin's LymphomaMultiple Myeloma
Swedish Orphan Biovitrum 145
Early research (Phase 1)Study completedNCT00830869
What this trial is testing

IXAZOMIB in Adult Patients With Advanced Nonhematologic Malignancies

Who this might be right for
Advanced Non-hematologic Malignancies
Millennium Pharmaceuticals, Inc. 116
Testing effectiveness (Phase 2)Study completedNCT00120705
What this trial is testing

Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy

Who this might be right for
NeoplasmsAnemia
Amgen 204
Early research (Phase 1)Study completedNCT00710528
What this trial is testing

Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Lymphoma, Non-Hodgkin (NHL)Acute Myeloid Leukemia (AML)+1 more
Gilead Sciences 192
Not applicableStudy completedNCT05734053
What this trial is testing

Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 222
Early research (Phase 1)WithdrawnNCT04043845
What this trial is testing

ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaWaldenstrom MacroglobulinemiaMantle Cell Lymphoma+1 more
Dana-Farber Cancer Institute
Not applicableStudy completedNCT04618081
What this trial is testing

Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL)

Who this might be right for
Lymphoma Nonhodgkin
Celgene 151
Early research (Phase 1)Study completedNCT00504972
What this trial is testing

Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies

Who this might be right for
Non-Hodgkin's LymphomaChronic Lymphocytic Leukemia
Weill Medical College of Cornell University 23
Testing effectiveness (Phase 2)WithdrawnNCT00003605
What this trial is testing

Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Hoag Memorial Hospital Presbyterian
Testing effectiveness (Phase 2)WithdrawnNCT02028039
What this trial is testing

IPI-145 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center
Next Page